Literature DB >> 28079352

The way forward in Italy for iodine.

Antonella Olivieri1, Caterina DI Cosmo2, Simona DE Angelis3, Roberto DA Cas4, Paolo Stacchini5, Augusto Pastorelli5, Paolo Vitti2.   

Abstract

Italy is dealing with iodine deficiency since ancient times. In 1848 an ad hoc committee appointed by the king of Sardinia, identified extensive areas afflicted by endemic goiter and endemic cretinism in Piedmont, Liguria and Sardinia. Since then many epidemiological studies have been conducted in our country. These showed that iodine deficiency was present not only in mountain areas but also in coastal areas. In 1972 the iodization of salt at 15 mg/kg was allowed by law and iodized salt was distributed on request to selected endemic areas. Five years later the distribution was extended to the whole country. However the sale of iodized salt was not mandatory at that time and only a small fraction of the Italian population started using iodized salt. In 1991 the content of iodine in the salt was raised to 30 mg/kg and in 2005 a nationwide salt iodization program was finally implemented. Some years later a nationwide monitoring program of iodine prophylaxis was also implemented. Since 2005 the sale of iodized salt in Italian supermarkets has increased (34% in 2006, 55% in 2012), although it has been observed that the use of iodized salt is still low in the communal eating areas and in the food industry. These data are coherent with recent epidemiological studies showing that some regions in our country are still characterized by mild iodine deficiency and a high frequency of goiter and other iodine deficiency disorders. This implies that further efforts should be made to successfully correct iodine deficiency in Italy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079352     DOI: 10.23736/S0026-4806.17.04877-7

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  7 in total

1.  Long lasting prophylaxis of iodine deficiency after a successful information campaign for iodized salt consumption.

Authors:  Domenico Meringolo; Davide Bianchi; Bartolomeo Bellanova; Massimo Torlontano; Giuseppe Costante
Journal:  Endocrine       Date:  2017-06-03       Impact factor: 3.633

2.  Incidence of primary congenital hypothyroidism and relationship between diagnostic categories and associated malformations.

Authors:  Gerdi Tuli; Jessica Munarin; Daniele Tessaris; Patrizia Matarazzo; Silvia Einaudi; Luisa de Sanctis
Journal:  Endocrine       Date:  2020-06-07       Impact factor: 3.633

3.  Endemic Goiter and Iodine Prophylaxis in Calabria, a Region of Southern Italy: Past and Present.

Authors:  Cinzia Giordano; Ines Barone; Stefania Marsico; Rosalinda Bruno; Daniela Bonofiglio; Stefania Catalano; Sebastiano Andò
Journal:  Nutrients       Date:  2019-10-11       Impact factor: 5.717

4.  Polypharmacy Among Headache Patients: A Cross-Sectional Study.

Authors:  Anna Ferrari; Carlo Baraldi; Manuela Licata; Cecilia Rustichelli
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

5.  A Detailed Analysis of the Factors Influencing Neonatal TSH: Results From a 6-Year Congenital Hypothyroidism Screening Program.

Authors:  Giulia Di Dalmazi; Maria Assunta Carlucci; Daniela Semeraro; Cesidio Giuliani; Giorgio Napolitano; Patrizio Caturegli; Ines Bucci
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

6.  Low-Salt Intake Suggestions in Hypertensive Patients Do not Jeopardize Urinary Iodine Excretion.

Authors:  Natale Musso; Lucia Conte; Beatrice Carloni; Claudia Campana; Maria C Chiusano; Massimo Giusti
Journal:  Nutrients       Date:  2018-10-19       Impact factor: 5.717

7.  Urinary Iodine Concentration in a Cohort of Adult Outpatients with Thyroid Diseases in Liguria 14 Years after the Law on Salt Iodization.

Authors:  Lucia Conte; Martina Comina; Eleonora Monti; Marilena Sidoti; Ornella Vannozzi; Lucia Di Ciolo; Flavia Lillo; Massimo Giusti
Journal:  Nutrients       Date:  2019-12-19       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.